https://www.onhealthcare.tech/p/echonext-clears-fda-for-six-structuralThoughts on Healthcare Markets & Technologyen2026-06-30T14:27:47+00:00EchoNext Clears FDA for Six Structural Heart Conditions Off a Standard ECG, Lands on OpenEvidence, and Logs the First AI-Triggered Heart Transplant: Reading the Cardiac Screening Land Grabhttps://www.onhealthcare.tech/p/part-ii-echonext-clears-fda-for-sixThoughts on Healthcare Markets & Technologyen2026-06-30T14:20:52+00:00Part II: EchoNext Clears FDA for Six Structural Heart Conditions Off a Standard ECG, Lands on OpenEvidence, and Logs the First AI-Triggered Heart Transplant: Reading the Cardiac Screening Land Grabhttps://www.onhealthcare.tech/p/part-i-echonext-clears-fda-for-sixThoughts on Healthcare Markets & Technologyen2026-06-30T14:19:09+00:00Part I: EchoNext Clears FDA for Six Structural Heart Conditions Off a Standard ECG, Lands on OpenEvidence, and Logs the First AI-Triggered Heart Transplant: Reading the Cardiac Screening Land Grabhttps://www.onhealthcare.tech/p/what-the-fda-actually-cleared-when-99dThoughts on Healthcare Markets & Technologyen2026-06-29T12:40:16+00:00What the FDA Actually Cleared When UpDoc Became the First Patient-Facing LLM Medical Device: A Stanford Insulin-Titration Trial, a Drug-Dose-Calculator Predicate, and the Real Shape of Clinical AIhttps://www.onhealthcare.tech/p/what-the-fda-actually-cleared-whenThoughts on Healthcare Markets & Technologyen2026-06-29T12:27:29+00:00What the FDA Actually Cleared When UpDoc Became the First Patient-Facing LLM Medical Device: A Stanford Insulin-Titration Trial, a Drug-Dose-Calculator Predicate, and the Real Shape of Clinical AI